ASTELLAS-015K-CL-RAJ1

Study Sponsor: Astellas

Study Title

Phase 2b Study of ASP015K – A Double-Blind, Placebo-Controlled, Dose-Finding Study in Moderate to Severe Rheumatoid Arthritis Patients –

Medicine or Vaccine (generic name)

peficitinib hydrobromide

Sponsor Identification Number

015K-CL-RAJ1

Trial Registry Identification Number(#'s)

NCT01649999

Medical Condition

Rheumatoid Arthritis

Phase

Phase 2

Link to Astellas Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

July 2020